Screener
Nutex Health Inc. NUTX EBITDA
Discontinued — last reported Q2 '26
EBITDA at other companies
Other financials
Where this comes from
Calculated from Nutex Health Inc.’s reported figures.
The source filing: Nutex Health Inc.’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:03 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054268
FAQ
- What is Nutex Health Inc.'s EBITDA?
- Nutex Health Inc. (NUTX) reported EBITDA of $127.04M in Q2 2026.
- How has Nutex Health Inc.'s EBITDA changed year-over-year?
- Nutex Health Inc.'s EBITDA increased by 226.3% year-over-year, from $38.93M to $127.04M.
- What is the long-term trend for Nutex Health Inc.'s EBITDA?
- Over 4 years (2021 to 2025), Nutex Health Inc.'s EBITDA has grown at a 25.0% compound annual growth rate (CAGR), from $121.12M to $296.16M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.
Ask your AI about Nutex Health Inc.'s ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude